307 related articles for article (PubMed ID: 29550194)
1. Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.
Lindsay BJ; Bonar MM; Costas-Cancelas IN; Hunt K; Makarkov AI; Chierzi S; Krawczyk CM; Landry N; Ward BJ; Rouiller I
Vaccine; 2018 Apr; 36(16):2147-2154. PubMed ID: 29550194
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.
Won SY; Hunt K; Guak H; Hasaj B; Charland N; Landry N; Ward BJ; Krawczyk CM
Vaccine; 2018 Dec; 36(52):8028-8038. PubMed ID: 30448064
[TBL] [Abstract][Full Text] [Related]
4. Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages.
Makarkov AI; Chierzi S; Pillet S; Murai KK; Landry N; Ward BJ
Vaccine; 2017 Aug; 35(35 Pt B):4629-4636. PubMed ID: 28712489
[TBL] [Abstract][Full Text] [Related]
5. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
[TBL] [Abstract][Full Text] [Related]
6. Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
Hendin HE; Pillet S; Lara AN; Wu CY; Charland N; Landry N; Ward BJ
Vaccine; 2017 May; 35(19):2592-2599. PubMed ID: 28389100
[TBL] [Abstract][Full Text] [Related]
7. A Single Intramuscular Dose of a Plant-Made Virus-Like Particle Vaccine Elicits a Balanced Humoral and Cellular Response and Protects Young and Aged Mice from Influenza H1N1 Virus Challenge despite a Modest/Absent Humoral Response.
Hodgins B; Yam KK; Winter K; Pillet S; Landry N; Ward BJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021303
[TBL] [Abstract][Full Text] [Related]
8. Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development.
Hong JY; Chen TH; Chen YJ; Liu CC; Jan JT; Wu SC
Antiviral Res; 2019 Apr; 164():12-22. PubMed ID: 30738089
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.
Shoji Y; Prokhnevsky A; Leffet B; Vetter N; Tottey S; Satinover S; Musiychuk K; Shamloul M; Norikane J; Jones RM; Chichester JA; Green BJ; Streatfield SJ; Yusibov V
Hum Vaccin Immunother; 2015; 11(1):118-23. PubMed ID: 25483524
[TBL] [Abstract][Full Text] [Related]
10. Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers.
Cohen AA; Yang Z; Gnanapragasam PNP; Ou S; Dam KA; Wang H; Bjorkman PJ
PLoS One; 2021; 16(3):e0247963. PubMed ID: 33661993
[TBL] [Abstract][Full Text] [Related]
11. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
Galarza JM; Latham T; Cupo A
Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
[TBL] [Abstract][Full Text] [Related]
12. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
[TBL] [Abstract][Full Text] [Related]
14. Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.
Pushko P; Sun X; Tretyakova I; Hidajat R; Pulit-Penaloza JA; Belser JA; Maines TR; Tumpey TM
Vaccine; 2016 Oct; 34(44):5235-5242. PubMed ID: 27663671
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
Xue C; Tian G; Chen X; Liu Q; Ma J; Xu S; Li X; Chen H; Cao Y
Virus Res; 2015 Jan; 195():35-42. PubMed ID: 25312452
[TBL] [Abstract][Full Text] [Related]
16. Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.
Pushko P; Pujanauski LM; Sun X; Pearce M; Hidajat R; Kort T; Schwartzman LM; Tretyakova I; Chunqing L; Taubenberger JK; Tumpey TM
Vaccine; 2015 Sep; 33(38):4975-82. PubMed ID: 26207590
[TBL] [Abstract][Full Text] [Related]
17. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X
Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810
[TBL] [Abstract][Full Text] [Related]
18. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
19. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.
D'Aoust MA; Lavoie PO; Couture MM; Trépanier S; Guay JM; Dargis M; Mongrand S; Landry N; Ward BJ; Vézina LP
Plant Biotechnol J; 2008 Dec; 6(9):930-40. PubMed ID: 19076615
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
